MedTrace Logo

Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC

NCT02143492 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2017-01-24

No results posted yet for this study

Summary

Standard treatment for kidney cancer is to remove the tumors from the body with surgery. The purpose of this clinical trial is to collect, preserve, and store excess kidney cancer tumor specimens that would normally be discarded after surgery.

Conditions

Sponsors & Collaborators

  • Argos Therapeutics

    lead INDUSTRY

Principal Investigators

  • Neal Shore, MD, FACP · Carolina Urologic Research Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02143492 on ClinicalTrials.gov